Results 161 to 170 of about 7,855 (224)

GPI-anchorless prion disease is sensitive to oxidative stress and shows potential for treatment with edaravone, based on iPS-derived neuron study. [PDF]

Cell Mol Life Sci
Matsuzono K, Honda H, Mashiko T, Koide R, Sakashita E, Endo H, Kitamoto T, Fujimoto S.   +7 more
europepmc   +1 more source

Edaravone dexborneol for the treatment of acute ischemic stroke: A systematic review and meta-analysis. [PDF]

Neuroradiol J
Mortezaei A, Emara M, Habibi MA, Yazdanian F, Mohammadzadeh I, Dmytriw AA, Rahmani R, Liebeskind DS.   +7 more
europepmc   +1 more source

Disrupted Lipid Metabolism Aggravates Ischemic Brain Injury: Targeting FDFT1 for Stroke Therapy. [PDF]

Mol Neurobiol
Yuan J, Liao YS, Zhang TC, Liu S, Ruan MM, Yang TT, Sun SQ, Xu LY, Xie XL, Zhao L.   +9 more
europepmc   +1 more source

Multi-Pathway Mechanisms of Engeletin in Ischemic Stroke: A Comprehensive Study Based on Network Pharmacology, Machine Learning, and Immune Infiltration Analysis. [PDF]

Int J Mol Sci
Xue H, Wen Y, Yang J, Zhang Y, Jin C, Li B, Ai Y, Zheng M, Wen B, Song K.   +9 more
europepmc   +1 more source

Intratympanic Injection of Edaravone for Idiopathic Sudden Sensorineural Hearing Loss with Profound Hearing Loss. [PDF]

J Int Adv Otol
Nitta Y, Sano H, Kurioka T, Yamashita T.
europepmc   +1 more source

Neuroprotective Agents With Reperfusion Therapies in Ischemic Stroke: Evidence From Recent Randomized Trials. [PDF]

Cureus
Wesley MJ, Gundala Raja H, Shahid MS, Akbar A, Jeyakumar D, Veluchamy E, Sivakumar M, Tahir F, Jiménez Royg D, Pant R, Rehman A.   +10 more
europepmc   +1 more source

Neuroprotective effect and possible mechanism of edaravone in rat models of spinal cord injury: a systematic review and network meta-analysis. [PDF]

Front Pharmacol
Zhou LY, Wang XB, Chen XQ, Li R, Yu BB, Pan MX, Fang L, Li J, Cui XJ, Yao M, Lu X.   +10 more
europepmc   +1 more source

Exploration of neuroprotective strategies in patients with acute promyelocytic leukemia complicated by cerebral hemorrhage. [PDF]

Front Med (Lausanne)
Hu J, Lai W.
europepmc   +1 more source

Amyotrophic Lateral Sclerosis: Pathophysiological Mechanisms and Treatment Strategies (Part 2). [PDF]

Int J Mol Sci
Tolochko C, Shiryaeva O, Alekseeva T, Dyachuk V.   +3 more
europepmc   +1 more source

Pan-Asian consortium for treatment and research in ALS (PACTALS) guidelines for management of amyotrophic lateral sclerosis. [PDF]

Lancet Reg Health West Pac
Vucic S, Shahrizaila N, Kano O, Menon P, Agustini S, Kulkantrakorn K, Atchayaram N, Lee YC, Prado MB, Ng KWP, Chai J, Son B, Talman P, Nghia HTT, Tuan LTQ, Shibuya K, Izumi Y, Atsuta N, Henderson RD, Cui L, Liu M, Ohnmar O, Rabani R, Hong YH, Sung JJ, Fan D, Raykar V, Kuwabara S, Kim SH, Sobue G, Kiernan MC.   +30 more
europepmc   +1 more source